Epiretinal Membrane & Cystoid Macular Oedema Post-cataract Surgery

Status Completed

Clinical Trial Summary

This study examines whether the presence of an epiretinal membrane affects the time to resolution, requirement for non-topical treatment, and outcome of pseudophakic cystoid macular oedema.

Clinical Trial Description

Cataract surgery is the most frequently performed surgery in the NHS. Cystoid macular oedema (CMO, inflammation and fluid accumulation in the central retina) is the most common visually significant complication following cataract surgery occurring in 1-2% of cases. Many cases resolve with topical anti-inflammatory eye drops. However some cases do not respond and require more invasive treatment modalities eg injections into the eye. If CMO remains persistent this can lead to permanent visual loss. There is little current knowledge on what factors lead to persistence in some cases compared to others. Epiretinal membrane (ERM, a fibrocellular membrane that can form on the inner retina) can be associated with a similar cystoid macular oedema that often does not resolve until the ERM is removed surgically. This study aims to look at whether the presence of an ERM affects how long it takes for cystoid macular oedema to resolve following cataract surgery and the requirement for non-topical treatment modalities. A prospective, non-interventional, observational study design is proposed. Eligible participants would be identified at one of several participating NHS hospitals in the Wessex Deanery. Subjects with evidence of CMO post-cataract surgery and commenced on treatment would be included. Treatment choice is at the discretion of the reviewing clinician and independent of the study protocol. Investigations performed would be only those conducted as part of standard care. Presence of epiretinal membrane would be determined from review of the medical records. Case- records of eligible participants would be reviewed over a 12-month period to assess response to treatment and type of treatment(s) used. Based on current surgical data recruitment would be estimated to take 18 months to achieve the 165 eligible participants to achieve statistical power. ;

Study Design

Related Conditions & MeSH terms

Edema
Epiretinal Membrane
Macular Edema
Pseudophakic Cystoid Macular Oedema

Clinical Trial Details

NCT number	NCT03965078
Study type	Observational
Source	Portsmouth Hospitals NHS Trust
Contact
Status	Completed
Phase
Start date	June 21, 2018
Completion date	July 15, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03332758` - Inflammasomes in Cell Death in FTMH, ERM, and RRD
Active, not recruiting	`NCT04130841` - Effects of Internal Limiting Membrane Peeling on Visual Function in Epiretinal Membrane Surgery	N/A
Recruiting	`NCT03713268` - Intraoperative OCT Guidance of Intraocular Surgery II
Terminated	`NCT01532765` - Randomized Trial Comparing Epiretinal Membrane Surgery With and Without Internal Limiting Membrane Removal	N/A
Completed	`NCT01474655` - Retinal Layers and Visual Rehabilitation After Epiretinal Membrane Removal	N/A
Active, not recruiting	`NCT04120311` - Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole	Phase 1
Completed	`NCT04445142` - Fovea ERM After Fovea-sparing ILM Peeling
Recruiting	`NCT01701518` - A Pilot Study of the Effectiveness of Intra-operative Ozurdex® in Vitrectomy Surgery for Epiretinal Membranes	N/A
Completed	`NCT01627977` - Association of Lutein, Zeaxanthin and Brilliant Blue in Chromovitrectomy	Phase 3
Completed	`NCT01771939` - Phacoemulsification and 25 Gauge (25G) Vitrectomy Versus Phacoemulsification Only in Idiopathic Epiretinal Membranes	N/A
Completed	`NCT00408720` - Comparison of a Spectral OCT/SLO With the Stratus OCT for Imaging Various Retinal Pathologies	N/A
Completed	`NCT05171621` - Measuring Subjective Quality of Vision and Metamorphopsia Before and After Epiretinal Membrane and Macular Hole Surgery
Active, not recruiting	`NCT04306718` - Cultivation of Hyalocytes From ILM and ERM Samples: a Pilot Study	N/A
Recruiting	`NCT01985490` - Change in Foveal Avascular Zone After Removal of Epiretinal Membrane and Internal Limiting Membrane	N/A
Completed	`NCT01238393` - Treatment of Epiretinal Membranes With Ranibizumab	N/A
Terminated	`NCT00333060` - Study of OT-551 Eye Drops to Prevent or Delay Progression of Nuclear Cataracts Following Vitreous Removal	Phase 2
Completed	`NCT05287269` - Ocular Coherence Tomography During Cataract Assessment
Recruiting	`NCT05138315` - Quantification of Metamorphopsia in Patients With Epiretinal Membranes	N/A
Recruiting	`NCT03661593` - Aniseikonia in Epiretinal Membrane Patients	N/A
Completed	`NCT03457584` - Effect of Air-tamponade on Intraretinal Cystoid Changes After Membrane Peeling	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Epiretinal Membrane and Cystoid Macular Oedema Post-cataract Surgery — EPIC

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms